Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Bacitracin A |
Is a |
False |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zinc bacitracin |
Is a |
False |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin C |
Is a |
False |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin B |
Is a |
False |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin methylene disalicylate |
Is a |
False |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin measurement |
Has measured component |
False |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin measurement |
Component |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bacitracin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bacitracin 50,000units injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin 500 unit/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin ophthalmic preparation |
Is a |
False |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing bacitracin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bacitracin 500 unit/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Bacitracin 5000000units powder for injection solution bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing bacitracin and polymyxin B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Bacitracin-containing product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing bacitracin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bacitracin-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing bacitracin in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zinc bacitracin |
Is modification of (attribute) |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin C |
Is modification of (attribute) |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin B |
Is modification of (attribute) |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin A |
Is modification of (attribute) |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin methylene disalicylate |
Is modification of (attribute) |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing bacitracin and neomycin and polymyxin B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing bacitracin and hydrocortisone and neomycin and polymyxin B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Product containing bacitracin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only bacitracin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bacitracin and neomycin and polymyxin B only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only bacitracin and neomycin and polymyxin B and pramocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Product containing only bacitracin and polymyxin B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only bacitracin and hydrocortisone and neomycin and polymyxin B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Product containing only bacitracin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only bacitracin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only bacitracin in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only bacitracin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only bacitracin in vaginal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bacitracin 500 unit/1 gram conventional release eye ointment (clinical drug) |
Has basis of strength substance (attribute) |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bacitracin 500 unit/1 gram conventional release eye ointment (clinical drug) |
Has precise active ingredient |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bacitracin 500 unit/g cutaneous ointment |
Has basis of strength substance (attribute) |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bacitracin 500 unit/g cutaneous ointment |
Has precise active ingredient |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bacitracin- and neomycin- and sulfacetamide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Bacitracin and neomycin and sulfacetamide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder |
Has precise active ingredient |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder |
Has basis of strength substance (attribute) |
True |
Bacitracin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |